Roche Finance Ltd 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-07 5:16 pm Purchase | 2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 441,038 15.350% | 317,344 (+256.56%) | Filing |
| 2021-02-16 07:03 am Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 123,694 8.100% | 123,694 (New Position) | Filing |